Difference between revisions of "Clinical Applications and Biological Targets Subcommittee"
Jump to navigation
Jump to search
m (→Call Summaries) |
m (→2014) |
||
| (20 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Reference Materials== | ==Reference Materials== | ||
| − | Presentations and Reports | + | |
| + | ==Presentations and Reports== | ||
| + | |||
| + | |||
| + | *[[Media:SWS - biomarker of Liver fibrosis-FINAL.pdf|SWS measurement(s) as biomarker(s) of Liver Fibrosis: Towards a Shared Vision - Claude Cohen-Bacrie, MS]] 25-February-2013 | ||
*[[Media:In Vitro Comparison of Ultrasound Based Elastography Techniques.pdf|In Vitro Comparison of Ultrasound Based Elastography Techniques (adapted from presentation by Stéphanie Franchi-Abella, MD, Caroline Elie, MD,PhD, Jean-Michel Correas, MD,PhD, ITEC 2012) - Claude Cohen-Bacrie, MS]] 22-October-2012 | *[[Media:In Vitro Comparison of Ultrasound Based Elastography Techniques.pdf|In Vitro Comparison of Ultrasound Based Elastography Techniques (adapted from presentation by Stéphanie Franchi-Abella, MD, Caroline Elie, MD,PhD, Jean-Michel Correas, MD,PhD, ITEC 2012) - Claude Cohen-Bacrie, MS]] 22-October-2012 | ||
| Line 11: | Line 15: | ||
==Call Summaries== | ==Call Summaries== | ||
| + | ==2015== | ||
| + | |||
| + | *[[Media:02 27 2015 QIBA US SWS Clinical Applications-DRAFT.pdf |02.27.2015 QIBA US SWS Clinical Applications Task Force Call Summary]] | ||
| + | *[[Media:01 30 2015 QIBA US SWS Clinical Applications-DRAFT.pdf |01.30.2015 QIBA US SWS Clinical Applications Task Force Call Summary]] | ||
| + | |||
| + | ==2014== | ||
| + | |||
| + | *[[Media:10 24 2014 QIBA US SWS Clinical Applications-FINAL.pdf |10.24.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:09 26 2014 QIBA US SWS Clinical Applications-FINAL.pdf |09.26.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:08 08 2014 QIBA US SWS Clinical Applications-FINAL.pdf |08.08.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:06 27 2014 QIBA US SWS Clinical Applications-FINAL.pdf |06.27.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:05 30 2014 QIBA US SWS Clinical Applications-FINAL.pdf |05.30.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:04 25 2014 QIBA US SWS Clinical Applications-DRAFT.pdf |04.25.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:03 28 2014 QIBA US SWS Clinical Applications-DRAFT.pdf |03.28.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:02 24 2014 QIBA US SWS Clinical Applications-FINAL.pdf |02.24.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:01 31 2014 QIBA US SWS Clinical Applications-DRAFT.pdf |01.31.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
==2013== | ==2013== | ||
| + | |||
| + | *[[Media:10 28 2013 QIBA US SWS Clinical Applications-FINAL.pdf |10.28.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:04 22 2013 QIBA US SWS Clinical Applications-DRAFT.pdf |04.22.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:03 18 2013 QIBA US SWS Clinical Applications-DRAFT.pdf |03.18.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
| + | *[[Media:02 25 2013 QIBA US SWS Clinical Applications-DRAFT.pdf |02.25.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
==2012== | ==2012== | ||
Latest revision as of 18:12, 3 April 2015
Draft Charge
Reference Materials
Presentations and Reports
- SWS measurement(s) as biomarker(s) of Liver Fibrosis: Towards a Shared Vision - Claude Cohen-Bacrie, MS 25-February-2013
Call Summaries
2015
- 02.27.2015 QIBA US SWS Clinical Applications Task Force Call Summary
- 01.30.2015 QIBA US SWS Clinical Applications Task Force Call Summary
2014
- 10.24.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 09.26.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 08.08.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 06.27.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 05.30.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 04.25.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 03.28.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 02.24.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 01.31.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary
2013
- 10.28.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 04.22.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 03.18.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 02.25.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary
2012
- 12.17.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 11.09.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 10.22.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary - DC
- 10.01.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 09.10.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 08.13.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 07.23.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary